Hoshina Y - Search Results

1

Serum matrix metalloproteinase-3 and fibrin degradation product levels correlate with clinical disease activity in rheumatoid arthritis.

Ichikawa Y, Yamada C, Horiki T, Hoshina Y, Uchiyama M. Ichikawa Y, et al. Among authors: hoshina y. Clin Exp Rheumatol. 1998 Sep-Oct;16(5):533-40. Clin Exp Rheumatol. 1998. PMID: 9779299

2

Abnormal expression of apoptosis-related antigens, Fas and bcl-2, on circulating T-lymphocyte subsets in primary Sjögren's syndrome.

Ichikawa Y, Arimori K, Yoshida M, Horiki T, Hoshina Y, Morita K, Uchiyama M, Shimizu H, Moriuchi J, Takaya M. Ichikawa Y, et al. Among authors: hoshina y. Clin Exp Rheumatol. 1995 May-Jun;13(3):307-13. Clin Exp Rheumatol. 1995. PMID: 7554556

3

Thrombomodulin levels in the plasma and joint fluid from patients with rheumatoid arthritis.

Ichikawa Y, Takaya M, Shimizu H, Moriuchi J, Uchiyama M, Morita K, Hoshina Y, Horiki T. Ichikawa Y, et al. Among authors: hoshina y. Tokai J Exp Clin Med. 1993 Dec;18(3-6):123-6. Tokai J Exp Clin Med. 1993. PMID: 7701524

4

Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.

Ichikawa Y, Takaya M, Shimizu H, Uchiyama M, Moriuchi J, Morita K, Hoshina Y, Horiki T. Ichikawa Y, et al. Among authors: hoshina y. Tokai J Exp Clin Med. 1993 Dec;18(3-6):133-8. Tokai J Exp Clin Med. 1993. PMID: 7701526

5

The coexistence of systemic sclerosis and rheumatoid arthritis in five patients. Clinical and immunogenetic features suggest a distinct entity.

Horiki T, Moriuchi J, Takaya M, Uchiyama M, Hoshina Y, Inada K, Inoko H, Tsuji K, Ichikawa Y. Horiki T, et al. Among authors: hoshina y. Arthritis Rheum. 1996 Jan;39(1):152-6. doi: 10.1002/art.1780390121. Arthritis Rheum. 1996. PMID: 8546724 Review.

6

Anti-agalactosyl IgG antibodies and isotype profiles of rheumatoid factors in Sjögren's syndrome and rheumatoid arthritis.

Ichikawa Y, Yamada C, Horiki T, Hoshina Y, Uchiyama M, Yamada Y, Toumatu J. Ichikawa Y, et al. Among authors: hoshina y. Clin Exp Rheumatol. 1998 Nov-Dec;16(6):709-15. Clin Exp Rheumatol. 1998. PMID: 9844764

7

Circulating soluble CD30 levels in primary Sjögren's syndrome, SLE and rheumatoid arthritis.

Ichikawa Y, Yoshida M, Yamada C, Horiki T, Hoshina Y, Uchiyama M. Ichikawa Y, et al. Among authors: hoshina y. Clin Exp Rheumatol. 1998 Nov-Dec;16(6):759-60. Clin Exp Rheumatol. 1998. PMID: 9844777 No abstract available.

8

Decay-accelerating factor (DAF, CD55)-negative T lymphocytes in the peripheral blood of Sjögren's syndrome patients.

Ichikawa Y, Masumoto A, Yoshida M, Yamada C, Horiki T, Hoshina Y, Uchiyama M, Takaya M. Ichikawa Y, et al. Among authors: hoshina y. Tokai J Exp Clin Med. 1996 Oct;21(3):121-8. Tokai J Exp Clin Med. 1996. PMID: 9239815

9

[Treatment with pilocarpine hydrochloride for sicca symptoms in Sjögren's syndrome].

Takaya M, Ichikawa Y, Yamada C, Hoshina Y, Horiki T, Uchiyama M. Takaya M, et al. Among authors: hoshina y. Ryumachi. 1997 Jun;37(3):453-7. Ryumachi. 1997. PMID: 9256028 Clinical Trial. Japanese.

10

HLA class II haplotypes associated with pulmonary interstitial lesions of polymyositis/dermatomyositis in Japanese patients.

Horiki T, Ichikawa Y, Moriuchi J, Hoshina Y, Yamada C, Wakabayashi T, Jackson K, Inoko H. Horiki T, et al. Among authors: hoshina y. Tissue Antigens. 2002 Jan;59(1):25-30. doi: 10.1034/j.1399-0039.2002.590105.x. Tissue Antigens. 2002. PMID: 11972875

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters